Fluvastatin Versus Hepatitis C Virus

Bader, Ted, M.D.32 enrolled

Overview

This is a dose finding and efficacy trial for fluvastatin versus hepatitis C.

Four different oral doses of fluvastatin will be used for 14 days and the viral load of hepatitis C will be measured weekly. This has been extended to different doses for 9-12 weeks.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Hepatitis C

Interventions

fluvastatinDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * HCV RNA positive Exclusion Criteria: * Testing positive for alcohol or marijuana

Locations (1)

VA Medical Center

Oklahoma City, Oklahoma, United States

Outcomes

Primary Outcomes

Viral Load Reduction, Liver test changes

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.